Advertisement
Advertisement
U.S. Markets closed
S&P Futures
4,171.00 -4.75 (-0.11%) Dow Futures
34,172.00 -34.00 (-0.10%) Nasdaq Futures
12,764.50 -12.25 (-0.10%) Russell 2000 Futures
1,975.40 -3.90 (-0.20%) Crude Oil
77.26 +0.12 (+0.16%) Gold
1,888.60 +3.80 (+0.20%)
Boston Scientific Corporation (BSX)
NYSE - NYSE Delayed Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
| Previous Close | 47.66 |
| Open | 47.07 |
| Bid | 47.76 x 1200 |
| Ask | 48.24 x 3100 |
| Day's Range | 47.05 - 48.27 |
| 52 Week Range | 34.98 - 48.87 |
| Volume | |
| Avg. Volume | 6,571,531 |
| Market Cap | 68.88B |
| Beta (5Y Monthly) | 0.82 |
| PE Ratio (TTM) | 62.54 |
| EPS (TTM) | 0.77 |
| Earnings Date | Jan 31, 2023 - Feb 06, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 48.95 |
- Simply Wall St.
A Look At The Fair Value Of Boston Scientific Corporation (NYSE:BSX)
In this article we are going to estimate the intrinsic value of Boston Scientific Corporation ( NYSE:BSX ) by...
- PR Newswire
Boston Scientific Receives FDA Clearance for LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System
Boston Scientific Corporation (NYSE: BSX) today announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the LithoVue™ Elite Single-Use Digital Flexible Ureteroscope System, the first ureteroscope system with the ability to monitor intrarenal pressure in real-time during ureteroscopy procedures.
- Simply Wall St.
Boston Scientific Full Year 2022 Earnings: EPS Misses Expectations
Boston Scientific ( NYSE:BSX ) Full Year 2022 Results Key Financial Results Revenue: US$12.7b (up 6.7% from FY 2021...
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
Advertisement
© 2023 Yahoo. All rights reserved.
